David Lee

Dr. David Lee is a Professor of Clinical Urology at UCI Health, University of California, Irvine, where he also serves as Director of the Comprehensive Prostate Cancer Center. He previously held the position of Chief of Urology at Penn Presbyterian Medical Center and was an Associate Professor of Surgery and Urology at the Perelman School of Medicine, University of Pennsylvania.

His research and clinical expertise lie in the field of urologic oncology, particularly in prostate cancer and robotic surgery. With over 6,300 robotic cases performed, Dr. Lee is among the most experienced robotic surgeons in the world. His work focuses on advancing minimally invasive techniques, improving surgical outcomes, and enhancing patient recovery through innovation in robot-assisted prostatectomy.

Dr. Lee has published over 200 articles, abstracts, and book chapters in the domain of minimally invasive urologic surgery. His scholarly output reflects a consistent focus on surgical quality, oncologic outcomes, and technological integration in urology. The breadth of his work spans clinical studies, surgical technique optimization, and quality improvement in cancer care.

He has received multiple recognitions for excellence in clinical practice, including:

• Best Doctors in America
• Castle Connolly Top Doctors
• Top Docs in Philadelphia Magazine

Dr. Lee has played key leadership roles in surgical quality and cancer care, serving as Surgeon Champion for the American College of Surgeons NSQIP program and as Cancer Liaison Physician. He directed the robotic urologic surgery fellowship at Penn Presbyterian Medical Center and contributed to the Abramson Cancer Center’s multidisciplinary initiatives. His work in education and training has helped shape the next generation of urologic surgeons, though specific advisees are not listed.

He is actively involved in professional organizations such as the American Urological Association, Society of Urologic Oncology, Society of Laparoscopic Surgeons, and the Asian Pacific Prostate Society. His affiliations reflect a strong commitment to advancing both clinical standards and collaborative research in urology.